Study to Investigate the Development of Lung Disease in Connective Tissue Disorders
felixioncool / Pixabay

Study to Investigate the Development of Lung Disease in Connective Tissue Disorders

A study record from clinicaltrials.gov is investigating the appearance of lung problems in patients with disorders affecting connective tissue. While prior research has documented the appearance of interstitial lung disease…

Continue Reading Study to Investigate the Development of Lung Disease in Connective Tissue Disorders
Study Finds The Drug Arava May be Useful for Juvenile Idiopathic Arthritis
JillWellington / Pixabay

Study Finds The Drug Arava May be Useful for Juvenile Idiopathic Arthritis

According to a story from Juvenile Arthritis News, a recent study has found that the drug leflunomide (marketed as Arava) may be a viable treatment for juvenile idiopathic arthritis patients,…

Continue Reading Study Finds The Drug Arava May be Useful for Juvenile Idiopathic Arthritis
Results From a Study of Gene Therapy for Cerebral Adrenoleukodystrophy Appear Positive
mcmurryjulie / Pixabay

Results From a Study of Gene Therapy for Cerebral Adrenoleukodystrophy Appear Positive

According to a story from PharmaTimes, the gene therapy company Bluebird bio has released updated results from a clinical study of its Lenti-D gene therapy as a treatment for patients…

Continue Reading Results From a Study of Gene Therapy for Cerebral Adrenoleukodystrophy Appear Positive
Fatty Liver Disease: When You’re Not Consuming Too Much Alcohol, You’re Producing It
Alexas_Fotos / Pixabay

Fatty Liver Disease: When You’re Not Consuming Too Much Alcohol, You’re Producing It

It's common knowledge that your Corona is doing your liver no favours. Heavy alcohol consumption isn’t great for your health. Reported in Cell Metabolism, new research gets more specific: the…

Continue Reading Fatty Liver Disease: When You’re Not Consuming Too Much Alcohol, You’re Producing It
Initial Trial Data Looks Promising for a Potential Treatment for Rare Epilepsies
geralt / Pixabay

Initial Trial Data Looks Promising for a Potential Treatment for Rare Epilepsies

According to a story from sectorpublishingintelligence.co.uk, the drug company Ovid Therapeutics Inc. has recently announced that the early data from its phase 2 clinical trial is mostly encouraging. This clinical…

Continue Reading Initial Trial Data Looks Promising for a Potential Treatment for Rare Epilepsies

A New European Consortium Dedicated to Finding and Treating Rare Diseases

A molecular biologist, Dr. Daria Julkowska, coordinates an international consortium in Paris that is largely funded through the 28-member European Union (EU). According to a report published in the Charcot-Marie-Tooth…

Continue Reading A New European Consortium Dedicated to Finding and Treating Rare Diseases
Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks
qimono / Pixabay

Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks

According to a story from Angioedema News, a recent study demonstrated the effectiveness of the medication Haegarda in reducing the number of swelling attacks experienced by hereditary angioedema patients. Preventative…

Continue Reading Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks

Many Americans Medical Data and Images Are Easily Accessible Online. What Does This Mean for Rare Disease Patients?

According to a story from ProPublica, the computer servers that store important patient medical data are surprisingly unprotected. This lack of protection appears to be a problem around the world,…

Continue Reading Many Americans Medical Data and Images Are Easily Accessible Online. What Does This Mean for Rare Disease Patients?
Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial
Free-Photos / Pixabay

Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial

According to a story from globenewswire.com, the gene and cell therapy company Abeona Therapeutics Inc. recently announced that has received a letter from the US Food and Drug Administration (FDA)…

Continue Reading Abeona Faces Clinical Hold from the FDA Ahead of Epidermolysis Bullosa Trial
A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses
mcmurryjulie / Pixabay

A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses

According to a post from gaucherdisease.org, clinical trials are an essential component to the development and testing of new therapies for Gaucher disease and other rare diseases. For some rare…

Continue Reading A Primer on Clinical Trials for Patients With Gaucher Disease and Other Rare Illnesses